Clinical Focus ›› 2021, Vol. 36 ›› Issue (8): 765-768.doi: 10.3969/j.issn.1004-583X.2021.08.019
-
Received:2021-06-01Online:2021-08-20Published:2021-08-30
CLC Number:
Cite this article
share this article
Add to citation manager EndNote|Ris|BibTeX
URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.08.019
| [1] |
Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993, 75(5):843-854.
pmid: 8252621 |
| [2] | Zhang F, Zhang Y, Lv X, et al. Evolution of an X-linked miRNA family predominantly expressed in mammalian male germ cells[J]. Mol Biol Evol, 2019(4):663-678. |
| [3] |
Fernandez N, Cordiner RA, Young RS, et al. Genetic variation and RNA structure regulate microRNA biogenesis[J]. Nat Commun, 2017, 8(3):151-154.
doi: 10.1038/s41467-017-00207-1 URL |
| [4] |
Bengone-Abogourin JG, Chelkha N, Verdin E, et al. Sequence similarities between viroids and human microRNAs[J]. Intervirology, 2020, 62(5-6):1-8.
doi: 10.1159/000499466 URL |
| [5] |
Li P, Chen Y, Juma CA, et al. Differential inhibition of target gene expression by human microRNAs[J]. Cells, 2019, 8(8):791
doi: 10.3390/cells8080791 URL |
| [6] |
Kouzarides T, Pandolfini L, Barbieri I, et al. Further evidence supporting N7-methylation of guanosine (m7G) in human microRNAs[J]. Mol Cell, 2020, 79(2):201-202.
doi: S1097-2765(20)30343-9 pmid: 32679073 |
| [7] | Do DN, Dudemaine PL, Fomenky B, et al. Integration of miRNA weighted gene co-expression network and miRNA-mRNA co-expression analyses reveals potential regulatory functions of miRNAs in calf rumen development[J]. Genomics, 2019, 3(4):849-859. |
| [8] | Chen Q, Zhao Z, Lan W, et al. Predicting miRNA-disease interaction based on recommend method[J]. Inf Discov Deliv, 2019, 48(1):35-40. |
| [9] |
Osmak G, Kiselev I, Baulina N, et al. From miRNA target gene network to miRNA function: miR-375 might regulate apoptosis and actin dynamics in the heart muscle via rho-GTPases-dependent pathways[J]. Int J Mol Sci, 2020, 21(24):9670.
doi: 10.3390/ijms21249670 URL |
| [10] | Dagmar P, Eva R, Lang I, et al. MiR-146a, miR-146b, and miR-155 increase expression of IL-6 and IL-8 and support HSP10 in an in vitro sepsis model[J]. PLoS One, 2017, 12(6):179-185. |
| [11] | Zhao H, Su W, Kang Q, et al. Natural killer cells inhibit oxaliplatin-resistant colorectal cancer by repressing WBSCR22 via upregulating microRNA-146b-5p[J]. Am J Cancer Res, 2018, 8(5):824-834. |
| [12] |
Chou KC, Liu RT, Kang HY. MicroRNA-146b: a novel biomarker and therapeutic target for human papillary thyroid cancer[J]. Int J Mol Sci, 2017, 18(3):636.
doi: 10.3390/ijms18030636 URL |
| [13] |
Katakowski M, Zheng X, Jiang F, et al. MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma[J]. Cancer Invest, 2010, 28(10):1024-1030.
doi: 10.3109/07357907.2010.512596 pmid: 20874002 |
| [14] |
Cai J, Xu L, Cai Z, et al. MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptor[J]. Mol Med Rep, 2015, 12(1):1549-1555.
doi: 10.3892/mmr.2015.3461 URL |
| [15] |
William P, Juliann C. Rational, biologically based treatment of EGFR -mutant non-small-cell lung cancer[J]. Nat Rev Cancer, 2010, 10(11):760-768.
doi: 10.1038/nrc2947 pmid: 20966921 |
| [16] |
Liu Y, Tsai MF, Wu SG, et al. MiR-146b-5p enhances the sensitivity of NSCLC to EGFR tyrosine kinase inhibitors by regulating the IRAK1/NF-κB pathway[J]. Mol Ther Nucleic Acids, 2020, 22:471-483.
doi: 10.1016/j.omtn.2020.09.015 URL |
| [17] |
Bai Q, Hunzeker ZE, Zhu Z, et al. Cranberry extract is a potent radiosensitizer for glioblastoma[J]. Anticancer Res, 2021, 41(7):3337-3341.
doi: 10.21873/anticanres.15121 URL |
| [18] | Alharbi M, Mobark NA, Balbaid A, et al. Regression of ETV6-NTRK3 infantile glioblastoma after first-line treatment with larotrectinib[J]. JCO Precis Oncol, 2020, 4(4):796-800. |
| [19] |
Xia H, Qi Y, Ng SS, et al. MicroRNA-146b inhibits glioma cell migration and invasion by targeting MMPs[J]. Brain Res, 2009, 1269(10):158-165.
doi: 10.1016/j.brainres.2009.02.037 URL |
| [20] |
Lim H, Devesa SS, Sosa JA, et al. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013[J]. JAMA, 2017, 317(13):1338-1348.
doi: 10.1001/jama.2017.2719 URL |
| [21] |
Jahanbani I, Abdallah A, Ali RH, et al. Discriminatory miRNAs for the management of papillary thyroid carcinoma and noninvasive follicular thyroid neoplasms with papillary-like nuclear features[J]. Thyroid, 2018, 28(3):319-327.
doi: 10.1089/thy.2017.0127 pmid: 29378472 |
| [22] |
Abdallah A, Jahanbani I, Mehdawi H, et al. The stress-activated protein kinase pathway and the expression of stanniocalcin-1 are regulated by miR-146b-5p in papillary thyroid carcinogenesis[J]. Cancer Biol Ther, 2020, 21(5):1-12.
doi: 10.1080/15384047.2019.1665395 URL |
| [23] |
Lima CR, Geraldo MV, Fuziwara CS, et al. MiRNA-146b-5p upregulates migration and invasion of different papillary thyroid carcinoma cells[J]. BMC Cancer, 2016, 16(1):108.
doi: 10.1186/s12885-016-2146-z URL |
| [24] |
Li LC, Bin LV, Chen B, et al. Inhibition of miR-146b expression increases radioiodine-sensitivity in poorly differential thyroid carcinoma via positively regulating NIS expression[J]. Biochem Biophys Res Commun, 2015, 462(4):314-321.
doi: 10.1016/j.bbrc.2015.04.134 URL |
| [25] |
Santisteban P, Eizaguirre G, Lamas L, et al. The miR-146b-3p/PAX8/NIS regulatory circuit modulates the differentiation phenotype and function of thyroid cells during carcinogenesis[J]. Cancer Res, 2015, 75(19):4119-4130.
doi: 10.1158/0008-5472.CAN-14-3547 URL |
| [26] |
Reck M, Rodríguez D, Robinson AG, et al. Pembrolizu-mab versus chemotherapy for PD-L1-positive non-small-cell lung cancer[J]. N Engl J Med, 2016, 375(19):1823-1833.
doi: 10.1056/NEJMoa1606774 URL |
| [27] |
Borghaei H, Pazares L, Horn L, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer[J]. New Engl J Med, 2015, 373(17):1627-1639.
doi: 10.1056/NEJMoa1507643 URL |
| [28] |
Lavin Y, Kobayashi S, Leader A, et al. Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses[J]. Cell, 2017, 169(4):750-765.
doi: 10.1016/j.cell.2017.04.014 URL |
| [29] |
Han Q, Cheng P, Yang H, et al. MiR-146b reverses epithelial-mesenchymal transition via targeting PTP1B in cisplatin-resistance human lung adenocarcinoma cells[J]. J Cell Biochem, 2019, 24(7):1-12.
doi: 10.1002/(ISSN)1097-4644 URL |
| [30] |
Li Y, Zhang HB, Dong YL, et al. MiR-146b-5p functions as a suppressor miRNA and prognosis predictor in non-small cell lung cancer[J]. J Cancer, 2017, 8(9):1704-1712.
doi: 10.7150/jca.16961 URL |
| [31] |
Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003-2005: a population-based study[J]. Int J Cancer, 2015, 136:1921-1930.
doi: 10.1002/ijc.29227 URL |
| [32] |
Li C, Miao R, Liu S, et al. Down-regulation of miR-146b-5p by long noncoding RNA MALAT1 in hepatocellular carcinoma promotes cancer growth and metastasis[J]. Oncotarget, 2017, 8(17):28683-28695.
doi: 10.18632/oncotarget.v8i17 URL |
| [33] |
Ding W, Yang H, Gong S, et al. Candidate miRNAs and pathogenesis investigation for hepatocellular carcinoma based on bioinformatics analysis[J]. Oncol Lett, 2017, 13(5):3409-3414.
doi: 10.3892/ol.2017.5913 URL |
| [34] |
Fan KY, Dholakia AS, Wild AT, et al. Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer[J]. J Natl Compr Canc Netw, 2019, 12(1):50-57.
doi: 10.6004/jnccn.2014.0006 URL |
| [35] |
Kudo M, Kobayashi T, Gotohda N, et al. Clinical utility of histological and radiological evaluations of tumor necrosis for predicting prognosis in pancreatic cancer[J]. Pancreas, 2020, 49(5):634-641.
doi: 10.1097/MPA.0000000000001539 URL |
| [36] |
Zhang B, Pan X, Cobb GP, et al. MicroRNAs as onco-genes and tumor suppressors[J]. Dev Biol, 2007, 302(1):1-12.
doi: 10.1016/j.ydbio.2006.08.028 URL |
| [37] |
Lin F, Wang X, Jie Z, et al. Inhibitory effects of miR-146b-5p on cell migration and invasion of pancreatic cancer by targeting MMP16[J]. J Huazhong Univ Sci Technolog Med Sci, 2011, 31(4):509.
doi: 10.1007/s11596-011-0481-5 URL |
| [38] |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics,2012[J]. CA Cancer J Clin, 2013, 65(2):87-108.
doi: 10.3322/caac.21262 URL |
| [39] | Byeon JS, Yang SK, Kim TI, et al. Colorectal neoplasm in asymptomatic Asians: a prospective multinational multicenter colonoscopy survey[J]. Gastrointest Endosc, 2007(65): 1015-1022. |
| [40] | Zhu Y, Wu G, Yan W, et al. MiR-146b-5p regulates cell growth, invasion, and metabolism by targeting PDHB in colorectal cancer[J]. Am J Cancer Res, 2017, 7(5):1136. |
| [1] | ZHAN Ji-dong;FU Qiang;CHENG Li-ming;GUAN Qing;DAI Yu-hong;TANG Ling. Analysis in clinical features and prognosis of malignancy associated hypercalcemia [J]. Clinical Focus, 2014, 29(1): 38-40. |
| [2] | . [J]. Clinical Focus, 2012, 27(22): 2001-2002. |
| [3] | . [J]. Clinical Focus, 2011, 26(22): 2018-2021. |
| [4] | . [J]. CLINICAL FOCUS, 2009, 24(15): 1363-0. |
| [5] | . [J]. CLINICAL FOCUS, 2009, 24(15): 1376-1378. |
| [6] | ZHANG Min;PAN Li;WEN Jia. Tissue Doppler assessment of anthracycline drugs on left ventricular function of patients with tumor [J]. CLINICAL FOCUS, 2009, 24(14): 1200-1202. |
| [7] | . [J]. CLINICAL FOCUS, 2009, 24(14): 1239-0. |
| [8] | . [J]. CLINICAL FOCUS, 2009, 24(7): 597-598. |
| [9] | . [J]. CLINICAL FOCUS, 2009, 24(1): 54-55. |
| [10] | . [J]. CLINICAL FOCUS, 2008, 23(21): 1590-1592. |
| [11] | . [J]. CLINICAL FOCUS, 2008, 23(19): 1396-1397. |
| [12] | HUA Zheng-xiang;DONG Jun-zhong;YANG Ya-ping;GUAN Hui-zhen;FENG Yong-lu. Relation between expression of mRNA in peripheral blood from patients with non-small cell lung cancer and prognosis of patients [J]. CLINICAL FOCUS, 2008, 23(3): 177-179. |
| [13] | DING Xiao-xu;SUN Bao-xin;DU Xin-sheng;XUE Cheng-yan. Change and clinical meaning in detection of carcinoembryonic antigen mRNA in ascites before and after intraperitoneal chemotherapy [J]. CLINICAL FOCUS, 2007, 22(16): 1151-1153. |
| [14] | . [J]. CLINICAL FOCUS, 2007, 22(5): 363-364. |
| [15] | . [J]. CLINICAL FOCUS, 2006, 21(3): 195-196. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||